Characterization and Outcomes of Iliac Vessel Injury in the 21st Century: A Review of the National Trauma Data Bank. (July 2013)

• Record Type: Journal Article
• Authors: Lauerman, Margaret H.; Rybin, Denis; Doros, Gheorghe; Kalish, Jeffrey; Hamburg, Naomi; Eberhardt, Robert T.; Farber, Alik
• Is Part Of: Vascular & endovascular surgery. Volume 47:Number 5(2013)
• Page Start: 325
• Page End: 330
• Publication Date: 2013-07
• Subjects: iliac artery -- iliac vein -- vascular trauma; Blood-vessels -- Surgery -- Periodicals; Blood-vessels -- Endoscopic surgery -- Periodicals; Vascular Surgical Procedures -- Periodicals; Angioplasty -- Periodicals; Surgical Procedures, Minimally Invasive -- Periodicals; Vascular Diseases -- surgery -- Periodicals; Vaisseaux sanguins -- Chirurgie -- Périodiques; Vaisseaux sanguins -- Chirurgie endoscopique -- Périodiques; 617.41
• DOI: 10.1177/1538574413487260
• Languages: English
• ISSNs: 1538-5744

Abstract

Introduction: Iliac vessel trauma (IVT) is traditionally associated with high mortality. We evaluated a modern series of patients with IVT to assess current outcomes and endovascular therapy use. Methods: We performed a retrospective review of the National Trauma Data Bank. Patients with IVT were stratified by blunt and penetrating mechanism and arterial and venous injury. Results: In blunt IVT, there was no significant difference in mortality between those with and without pelvic fractures (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.36-1.06). In penetrating IVT, combined arterial and venous IVT was associated with higher mortality (OR 1.70, 95% CI 1.06-2.70) compared to isolated arterial IVT. Isolated venous IVT was associated with lower mortality (OR 0.55, 95% CI 0.35-0.85) compared to isolated arterial IVT. Endovascular stenting was utilized in 11.3% of blunt IVT with pelvic fractures, 6.3% of blunt IVT without pelvic fractures, and 1.8% of penetrating IVT. Conclusion: Iliac Vessel Trauma has significant mortality. Endovascular intervention for IVT is applied sparingly.